Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-04-10
1993-12-14
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546174, 546180, C07D21514, A61K 3147
Patent
active
052703240
ABSTRACT:
Compounds having the formula I: ##STR1## are leukotriene antagonists and inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
REFERENCES:
patent: 4851409 (1989-07-01), Young et al.
patent: 4920132 (1990-04-01), Huang et al.
patent: 4929626 (1990-05-01), Mohrs et al.
patent: 4962203 (1990-10-01), Young et al.
patent: 4970215 (1990-11-01), Mohrs et al.
Guay Daniel
Labelle Marc
Zamboni Robert
Daniel Mark R.
DiPrima Joseph F.
Merck Frosst Canada Inc.
Springer David B.
LandOfFree
Fluorinated hydroxyalkylquinoline acids as leukotriene antagonis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluorinated hydroxyalkylquinoline acids as leukotriene antagonis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluorinated hydroxyalkylquinoline acids as leukotriene antagonis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1705818